Found: 2
Select item for more details and to access through your institution.
The association between BMI and BSA–temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 6, p. 473, doi. 10.1093/nop/npz006
- By:
- Publication type:
- Article
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac152
- By:
- Publication type:
- Article